undamentalytics Newsletter

Hassan Emil E: insider trades

Director at National Healthcare Corp. No open-market purchases and 30 sales not made under a pre-set plan, reported from May 17, 2011 to June 23, 2026.

What happened after Hassan Emil E’s sales?

After their sales, the shares moved −4.6% against the index over 12 months on average (a negative figure means selling was the right call); 69% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Hassan Emil E: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 30 −6.1% −6.2% 57% 9 0.20 0.85 No reliable evidence
Sales, 12 months after the report 26 −4.6% −7.6% 69% 7 −0.78 0.47 No reliable evidence
Sales, 12 months after the trade 26 −3.9% −7.1% 69% 7 −0.46 0.66 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
National Healthcare Corp NHC —030May 17, 2011June 23, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 23, 2026June 22, 2026 NHC Sale $1,187,400 +6.3%not yetnot yet
June 18, 2026June 16, 2026 NHC Sale $312,569 +7.1%not yetnot yet
November 26, 2025November 25, 2025 NHC Sale $1,038,900 +25.8%not yetnot yet
November 12, 2025November 12, 2025 NHC Sale $731,500 +29.0%not yetnot yet
December 11, 2023December 8, 2023 NHC Sale $663,750 −7.9%+4.3%+8.7%
December 6, 2023December 4, 2023 NHC Sale $641,250 −2.4%+9.9%+15.8%
March 17, 2021March 15, 2021 NHC Sale $151,127 −14.6%−22.0%−17.9%
August 20, 2018August 16, 2018 NHC Sale $382,400 +11.2%+7.2%+6.0%
June 14, 2018June 14, 2018 NHC Sale $349,900 +0.2%+11.7%+11.9%
November 13, 2014November 12, 2014 NHC Sale $38,937 +3.4%+7.5%+5.0%
November 10, 2014November 7, 2014 NHC Sale $151,119 +1.5%+4.1%+5.2%
March 17, 2014March 17, 2014 NHC Sale $110,160 −4.5%+7.2%+7.7%
March 5, 2014March 4, 2014 NHC Sale $118,453 +1.2%+8.6%+6.4%
September 23, 2013September 23, 2013 NHC Sale $245,000 +4.8%−3.5%−1.8%
September 26, 2012September 25, 2012 NHC Sale $242,500 +0.8%−15.4%−15.8%
September 14, 2012September 13, 2012 NHC Sale $197,259 +5.0%−14.6%−11.7%
August 22, 2012August 21, 2012 NHC Sale $37,741 +0.9%−11.4%−13.1%
June 21, 2011June 21, 2011 NHC Sale $55,776 −23.7%−15.1%−12.8%
June 10, 2011June 9, 2011 NHC Sale $139,104 −23.4%−14.8%−11.5%
June 3, 2011June 2, 2011 NHC Sale $10,493 −21.8%−7.9%−7.7%
June 3, 2011June 1, 2011 NHC Sale $56,819 −21.8%−7.9%−8.2%
June 1, 2011May 31, 2011 NHC Sale $232,881 −20.0%−7.7%−6.4%
May 31, 2011May 27, 2011 NHC Sale $29,980 −17.8%−8.2%−7.5%
May 26, 2011May 26, 2011 NHC Sale $45,974 −18.1%−7.5%−7.1%
May 26, 2011May 25, 2011 NHC Sale $21,855 −18.1%−7.5%−8.1%
May 26, 2011May 24, 2011 NHC Sale $17,613 −18.1%−7.5%−8.6%
May 24, 2011May 23, 2011 NHC Sale $26,982 −15.6%−8.1%−8.3%
May 23, 2011May 20, 2011 NHC Sale $22,485 −16.3%−8.6%−6.6%
May 20, 2011May 19, 2011 NHC Sale $36,905 −17.4%−8.3%−6.7%
May 17, 2011May 13, 2011 NHC Sale $32,903 −19.1%−5.2%−7.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hassan Emil E traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.